EISENBERG OR enters NEUROSENSE THERAPEUTICS LTD. with 1.05M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/1/2026ACC: 0001213900-26-038542
Officer· Chief Financial Officer
Since Mar 2026
1.05M
Baseline shares
100% direct
1.05M
Direct ownership
3 positions
87.67K
Derivative underlying
2 instruments
3
Security positions
All direct
Non-Derivative Holdings3
Ordinary Shares
DirectShares owned341.51K
Ordinary Shares
DirectShares owned573.13K
Ordinary Shares
DirectShares owned139.42K
Total
1.05M direct1.05M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 341.51K | Direct |
| Ordinary Shares | 573.13K | Direct |
| Ordinary Shares | 139.42K | Direct |
| Total | 1.05M | 1.05M direct |
Derivative Holdings2
Warrants to purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
66.67K
Shares owned
N/A
Exercise price
0.75
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
21K
Shares owned
N/A
Exercise price
0.033
Expiration
—
Exercise window
—
Total
Underlying
87.67K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants to purchase Ordinary Shares Direct | Ordinary Shares | 0.75 | — | — | 66.67K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 0.033 | — | — | 21K | N/A |
| Total | 87.67K | 0.00 | ||||